Kyp Sirinakis

MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland.

Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

FASgen LLC was engaged in pharmaceutical preparations. Its products are FAS-detect IHC and FAS-detect ELISA. The company was founded by Albert H. Owens Jr., Craig A. Townsend, James D. Dick and in 1999 and was headquartered in Baltimore, MD.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Harpoon Medical, Inc. develops surgical services. It offers an image-guided, minimally invasive surgical tool for mitral valve repair that enables surgeons to access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The company was founded by James S. Gammie and Peter Wilson in July 2013 and is headquartered in Baltimore, MD.

Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019.

Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom.